MedPath

Effect of high frequency rTMS on negative symptoms and cognitive functioning in schizophrenia

Conditions
- schizophrenia- negaive symptoms- transcranial magnetic stimulation- TMS- cognitive functioning
Registration Number
NL-OMON25191
Lead Sponsor
niversity Medical Center Groningen (UMCG)
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
32
Inclusion Criteria

1. Participants must be 18 years or older.

2. They must be diagnosed with schizophrenia and the diagnosis must be confirmed by a standardised psychiatric assessment, the Schedules for Clinical Assessment in Neuropsychiatry (SCAN 2.1).

Exclusion Criteria

1. Exclusion criteria include rTMS and MRI contraindications (e.g. a personal or family history of epileptic seizures, history of brain surgery, intracerebral or pacemaker implants, inner ear prosthesis or other metal prosthetics/implants).

2. Neurological disorders, a head injury with loss of consciousness in the past.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome of the study is a significant decline of negative symptoms and cognitive dysfunctioning after bilateral high frequency rTMS treatment of the DLPFC.
Secondary Outcome Measures
NameTimeMethod
The secondary outcome of the study is increased cortical activation in the DLPFC after rTMS treatment, measured through a fMRI study.
© Copyright 2025. All Rights Reserved by MedPath